The Australasian Clinical Tuberculosis Network (ACTnet) is a collaborative clinical research group spanning Australia and
ACTnet engages and supports clinicians and researchers across the two countries to conduct high-quality research of national and international significance.
Tuberculosis remains one of the leading causes of death worldwide, and is an important contributor to morbidity among migrants arriving in Australia and New Zealand. There are around 1300 reported cases of TB in Australia each year, and a further 300 in New Zealand. Included in these figures are cases of multi-drug resistant (MDR) TB which pose significant barriers to treatment and management of the disease. The Australian government has committed to the global elimination of TB by 2030, but to do so requires the development of innovative new strategies, based on high-quality research, that has national and international reach. ACTnet provides a platform for this research by connecting and supporting investigators to conduct multi-center and collaborative studies, in order to best inform future direction in TB control.